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Abstract
Background: Apocrine mixed tumor is usually found in parotid glands. Its cutaneous counterpart is rare and its
occurrence in the eyelids is even rarer.
Case presentation: This study reports an apocrine mixed tumor of the upper left eyelid in a 68 year-old lady with
a history of breast cancer. This mass appeared about 3 years ago, as a slowly growing small nodule, and was
completely excised. On microscopic examination, an encapsulated mass with epithelial and mesenchymal features
was seen. The epithelial component presented tubular, cystic and infundibular structures while the mesenchymal
component was fibrous in some areas and myxoid in others. Plasmacytoid hyaline cells, lipomatous change and
focal calcification were appreciated focally. Immunohistochemical studies showed stromal staining for CD10, S-100,
α-SMA and p63. Luminal cell layer of the epithelial component was positive for EMA, CK-7 and GCDFP-15 markers.
The capsule was unbreached and no satellite lesions were appreciated. No evidence of relapse was evident after
16 months of follow-up.
Conclusions: The diagnosis of eyelid tumors of adnexal origin can be challenging because they are rare and
display a wide range of morphological patterns, as the tumor cells might differentiate along any line of the
folliculosebaceous-apocrine system. Immunohistochemistry helps improve the accuracy of assessment.
Background
Pleomorphic adenoma or benign mixed tumor is a dual
cell neoplasia, which is the reason for the designation of
this tumor as mixed. The first component is of epithelial
(apocrine or eccrine) origin and morphologically shows
various arrangements including ductal, cystic and solid
while also showing structures with a double-layer of
inner cuboidal and outer myoepithelial cells. Immuno-
histochemical study of myoepithelial markers reveals the
immunologic nature of the outer cell layer. The second
component is of mesenchymal origin and shows fibrous,
myxoid, mucoid, and chondroid features. The mesenchy-
mal component is also very diverse and reveals mucoid,
myxoid, chondroid, osseous, and adipose features. Mixed
tumor is usually found in parotid glands. Cutaneous
pleomorphic adenoma is rare and its occurrence in the
eyelids is even rarer. This tumor is of variants; eccrine
and apocrine tumors. The latter is identified by its mor-
phological features and immunohistochemistry helps to
establish its diagnosis. It is not always possible to specify
the exact origin of the tumor. Complete surgical removal
is the treatment of choice.
Case presentation
A 68 year-old woman with a history (12 years ago) of
breast cancer presented with a 0.7 cm × 0.7 cm solitary
nodule of the left upper eyelid. The mass appeared three
years ago in the central lid, was slowly growing and the
patient reported no pain. On physical examination, the
mass was firm, freely moving and not tender. The over-
lying skin did not reveal any abnormality. The clinical
diagnosis was epidermal inclusion cyst and the mass was
removed for diagnostic as well as cosmetic reasons.
The specimen was received in 10 % buffered formalin.
On gross inspection, a tan well-circumscribed dermal
mass measuring 0.7 cm × 0.7 cm × 0.5 cm was seen. The
overlying skin ellipse (0.8 cm × 0.4 cm) was grossly unre-
markable with a rubbery and firm consistency. On the cut
surface, it was apparently homogenous. There was no
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attachment to underlying structures. On sectioning, no
gross keratinous or cheesy material was seen.
Hematoxillin and eosin staining of the sections re-
vealed a dermal mass with fibrous encapsulation (Fig. 1a).
The tumor consisted of dual epithelial and stromal
components. The former consisted of interconnected
cords, tubules, solid islands and cystic structures show-
ing a two layer arrangement of cuboidal epithelial cells
(Fig. 1b). The tubular structures showed decapitation
secretion or apical snouting of the inner cell layer.
Keratotic lamella-filled cysts lined with squamous
epithelium were seen. The latter contained anucleated
squamous cells. As a result of the eccentrically placed
nuclei, hyaline epithelial cells were observed focally to
have a plasmacytoid appearance (Fig. 1c). The stroma
was myxoid with intersecting collagen fibers, focal
lipomatous differentiation (Fig. 1d) and calcification
(Fig. 1e). Capsular breach, hypercellularity, atypia, high
mitotic figures or satellite lesions were not appreciated.
Microscopically, the tumor had no connection to the
palpebral lobe of the lacrimal gland.
Immunohistochemistry
To better characterize the cell nature, differentiation, and
protein expression of this tumor, we performed an ex-
tended immunohistochemistry panel for CK7 (cytokera-
tin-7-7), EMA (epithelial membrane antigen), GCDFP-15
(gross cystic disease fluid protein-15), α-SMA (alpha-
smooth muscle actin), S-100, p63, and CD10 immuno-
markers (Novocastra Laboratories; Leica Microsystems).
Both internal and external positive and negative controls
were assessed according to personal experience and
manufacturer instructions. CK-7 immunostaining was
positive at the inner cell layer of the ducts, tubules and
cystic structures (luminal cells). The abluminal (basal/
myoepithelial) cells and stromal component were not re-
active (Fig. 2a). EMA which is present in a variety of glan-
dular (secretory) epithelia such as breast, eccrine and
apocrine glands was positive in the luminal cells of the
epithelial component and displayed an apical staining pat-
tern (Fig. 2b); the sebaceous cells were bubbly positive
(Fig. 2c). Some non-specific epidermal staining was ob-
served. GCDFP-15 immunostaining showed strong lu-
minal positivity (Fig. 2d). The abluminal and stromal cells
were negative. Α-SMA reacts with tumors arising from
smooth muscles and myoepithelial cells and was negative
at epithelial component, but showed focal positive stromal
staining (Fig. 2e). The vascular walls within the tumor
showed strong cytoplasmic reactivity. S-100 immunostain-
ing revealed strong stromal positivity, especially in the li-
pomatous areas (Fig. 2f). The epithelial component was
not reactive. The p63 immunostaining showed positivity
at the abluminal cells of tubules and cystic structures. The
stromal cells were focally positive (Fig. 2g). CD10, or
CALLA (common acute lymphoblastic leukemia antigen)
is a cell surface antigen that has been confirmed as a
myoepithelial cell marker. CD10 immunostaining showed
reactivity in abluminal cells and stromal fibrocytes
(Fig. 2h). The plasmacytoid cells were also positive for this
marker (Fig. 2i).
Fig. 1 Histomorphological features of the apocrine mixed tumor. a Low power view of the tumor with unbreached fibrous capsule and intact
epidermis at the left lower corner. Dual epithelial and mesenchymal components are seen (hematoxylin and eosin × 40). b Bilayer arrangement
and snouting of the epithelial cells around the ducts and cystic structures (hematoxylin and eosin × 100). c Plasmacytoid differentiation of tumor
cells or hyaline cells (hematoxylin and eosin × 400). d Lipomatous differentiation (hematoxylin and eosin × 400). e Cystic structures with lamellar
keratinized material, calcification and histiocytic giant cells (hematoxylin and eosin × 40)
Azari-Yam and Abrishami Diagnostic Pathology  (2016) 11:32 Page 2 of 5
Discussion
A rare case of apocrine mixed tumor of the eyelid has
been reported in a 68-year old lady with a history of
breast cancer. A metastatic process was not considered
clinically for the eyelid tumor because of its slow growth
rate and mobile nature. Apocrine mixed tumors most
commonly occur in the salivary glands but are also
found in other sites. To the best of our knowledge, only
25 tumors of this type have been reported in the eyelid
[1–12]. In the periorbital area, the most common site of
origin is the lacrimal gland (Krause’s glands) [13, 14].
Sweat glands, have more rarely been reported as the site
of origin [15]. In some cases, the exact origin of the
tumor could be determined by thorough clinical examin-
ation. Correlation of physical signs and a thorough
search for any remnants of the possibly affected lacrimal
gland lobe might help to determine the tumor origin.
Our case showed no attachment to the lacrimal gland.
The hematoxiline eosin staining is the gold standard for
diagnosis of tumors arising in skin adnexa and IHC is
considered supplementary. Some studies have emphasized
the importance of immunohistochemistry in the diagnosis
of mixed tumors [16]. To better characterize cell nature,
differentiation, and protein expression of this tumor at
this rare site, we performed an extended immunohisto-
chemistry panel. Immunohistochemical analysis showed
stromal staining for CD10, S-100, α-SMA and p63.
The luminal cell layer of the epithelial component
was positive for EMA, CK-7 and GCDFP-15 markers.
These findings are consistent with the biphasic nature
of this tumor. Similar findings have been reported in
previous studies [17, 18].
Immunostaining with myoepithelial markers for S-100,
p63, and CD10 is also of benefit for detection of remin-
iscent benign myoepithelial cells in cases of carcinoma
ex pleomorphic adenoma [19].
An interesting feature of our case is that the tumor
displays a wide range of differentiation and metaplastic
changes in its epithelial, myoepithelial and stromal com-
ponents. The spectrum of metaplastic changes included
Fig. 2 Representative photomicrographs of immunophenotyping in apocrine mixed tumor of the eyelid. a Strong positive CK-7 staining of the
ductal luminal cells. The abluminal and stromal cells are negative. b Apical staining of luminal cells with epithelial membrane antigen (EMA)
marker. c Strong bubbly EMA positive sebaceous cells of the overlying non-tumoral skin. d Strong luminal cell reactivity with gross cystic disease
fluid protein-15 (GCDFP-15). e Negative epithelial component with α-SMA (top and left) and focal positive stromal cells. f S-100 strong positivity
of lipomatous cells of the stroma and negative epithelial component (right and bottom left corner). g P63 shows positive abluminal cells of the
ductal structure with dispersion or streaming of the myoepithelial components into stroma. The luminal cell layer is negative. h Stromal and focal
abluminal CD10 reactivity. i Staining of plasmacytoid cells with CD10 marker. Original magnifications: ×400 for (a), (b), (d) and (e); ×1000 for (c),
(f), (g), (h), and (i)
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changes in the myoepithelial component documented as
hyaline or plasmacytoid cells, spindling, and collagenous
spherulosis. Stromal alterations included adipose meta-
plasia and calcification.
The histomorphological differential diagnosis includes
eccrine and apocrine hidrocystomas, fibroadenoma,
hidradenoma, mucinous adenocarcinoma, adenoid cystic
carcinoma and rare soft tissue tumors like the myxoid
chondrosarcoma. Differentiation from hidrocystomas was
mostly based on clinical grounds as apocrine hidrocysto-
mas most commonly appear as translucent papules or
nodules. Other differentials are ruled out mostly on histo-
morphological basis. The tumor in this study presented
hyaline cells which are usually absent in other types of ad-
nexal tumors [16]. Cellular atypia and pleomorphism were
absent in our tumor, a feature which differentiates it from
malignant entities.
By morphologic features, the apocrine versus eccrine
origin of the tumor can be inferred. Apocrine glands are
restricted to the axilla, nipples, genital and anal areas. In
the periocular area, they emerge as glands of Moll.
The most characteristic differentiating feature which
favors an apocrine origin is the double layer arrange-
ment of the branching tubular structures. It is widely
accepted that the outer epithelial layer of these
structures is of myoepithelial origin confirmed by
immunophenotypic studies. Another feature favoring
apocrine origin is the scalloping of the glands towards
the luminae or decapitation secretion. In our case,
both features were present.
The benign versus malignant nature of this tumor
could be inferred by some clinical and histomorphologi-
cal features. Despite their innocent morphological ap-
pearance, it is widely accepted that mixed tumors could
be infiltrative or malignant. The most reliable guide to
establishing the malignant nature of an adnexal tumor is
the demonstration of an infiltrative margin or aggression
to the capsule. High mitoses counts have not been
agreed upon as a factor of recurrence or metastasis.
Hypercellularity, atypia and pleomorphism have been
mentioned as factors to classify the tumor as potentially
malignant. In the case of the tumor reported here, an
unbreached encapsulation was evident. Hypercellularity,
atypia, high mitotic figures or satellite lesions were not
appreciated. Focal calcification was seen in our tumor
(Fig. 1d) however, it is not a malignancy indicator [17].
Some studies have emphasized the importance of
immunohistochemistry, in the diagnosis of mixed tu-
mors [18].
The diagnosis of eyelid tumors of adnexal origin can
be challenging because they display a wide range of
morphological patterns, as the tumor cells might dif-
ferentiate along any line of the folliculosebaceous-
apocrine system.
Conclusion
Apocrine mixed tumor can arise from adnexal structures
of the eyelid and has dual (myo) epithelial and mesenchy-
mal components. Its encapsulated margin and bland cyto-
logical features help establish it as a benign lesion. In
clinical practice, the histopathological diagnosis of adnexal
tumors is made carefully through the assessment of the
growth pattern of the histological architecture, cellular
differentiation, and features of the tumor stroma, along
with the clinical information. Immunohistochemistry
helps improve the accuracy of assessment. Complete sur-
gical excision is the treatment of choice.
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